These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 979659)

  • 41. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    Saccà L; Sherwin R; Hendler R; Felig P
    J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Blood insulin, glucagon and glucose levels in latent diabetes mellitus determined during glucose tolerance test (effect of phenformin)].
    Tikhonova NE
    Ter Arkh; 1982; 54(10):12-6. PubMed ID: 6758166
    [No Abstract]   [Full Text] [Related]  

  • 43. Hyperkalemia and hyperglycemic increments in plasma potassium in diabetes mellitus.
    Popp D; Achtenberg JF; Cryer PE
    Arch Intern Med; 1980 Dec; 140(12):1617-21. PubMed ID: 7006540
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glucose, insulin, pancreatic glucagon and glucagon-like immunoreactive materials in the plasma of normal and diabetic children. Effect of the initial insulin treatment.
    Matsuyama T; Hoffman WH; Dunbar JC; Foà NL; Foà PP
    Horm Metab Res; 1975 Nov; 7(6):452-6. PubMed ID: 1213649
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Ratio of somatostatin-glucagon secretion in diabetes mellitus].
    Kostiuk EP
    Fiziol Zh (1978); 1985; 31(2):195-201. PubMed ID: 2860024
    [No Abstract]   [Full Text] [Related]  

  • 46. Effects of ingestion of triglyceride or galactose on secretion of gastric inhibitory polypeptide and on responses to intravenous glucose in normal and diabetic subjects.
    Ross SA; Dupre J
    Diabetes; 1978 Mar; 27(3):327-33. PubMed ID: 640238
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus.
    Gutniak M; Orskov C; Holst JJ; Ahrén B; Efendic S
    N Engl J Med; 1992 May; 326(20):1316-22. PubMed ID: 1348845
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of dietary fiber on glucose and hormone responses to a mixed meal in normal subjects and in diabetic subjects with and without autonomic neuropathy.
    Levitt NS; Vinik AI; Sive AA; Child PT; Jackson WP
    Diabetes Care; 1980; 3(4):515-9. PubMed ID: 6257457
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Uncontrolled diabetes mellitus and hyperglucagonemia associated with an islet cell carcinoma.
    Leichter SB; Pagliara AS; Grieder MH; Pohl S; Rosai J; Kipnis DM
    Am J Med; 1975 Feb; 58(2):285-93. PubMed ID: 46704
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of a sensitive and specific radioimmunoassay for pancreatic glucagon in human plasma and its clinical application.
    Borghi VC; Wajchenberg BL; Albuquerque RH
    Clin Chim Acta; 1984 Jan; 136(1):39-48. PubMed ID: 6692564
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma insulin and glucose profiles in normal, obese, and diabetic persons.
    Genuth SM
    Ann Intern Med; 1973 Dec; 79(6):812-22. PubMed ID: 4761908
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of low-dose recombinant human insulin-like growth factor-I on insulin sensitivity, growth hormone and glucagon levels in young adults with insulin-dependent diabetes mellitus.
    Acerini CL; Harris DA; Matyka KA; Watts AP; Umpleby AM; Russell-Jones DL; Dunger DB
    Metabolism; 1998 Dec; 47(12):1481-9. PubMed ID: 9867078
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Abnormal response of pancreatic glucagon to glycemic changes in diabetes mellitus.
    Ohneda A; Watanabe K; Horigome K; Sakai T; Kai Y; Oikawa S
    J Clin Endocrinol Metab; 1978 Mar; 46(3):504-10. PubMed ID: 752036
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Response of gut glucagon-like immunoreactivity to hypoglycemia in dogs.
    Ohneda A; Sasaki I; Naito H; Toda M; Ohneda M; Koizumi F
    Am J Physiol; 1989 Mar; 256(3 Pt 1):E431-8. PubMed ID: 2646947
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Glucagon and insulin levels in diabetes mellitus patients].
    Kosilova ES; Lobanova AM; Starosel'tseva LK; Perelygina AA
    Probl Endokrinol (Mosk); 1982; 28(1):3-6. PubMed ID: 7038662
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Maximum stimulation of insulin secretion in children with chemical diabetes and obesity.
    Castells S; Avruskin T; Reddy CM; Hashemi SE
    Am J Med Sci; 1976; 271(1):35-9. PubMed ID: 943938
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Somatostatin does not alter insulin-mediated glucose disposal.
    Meneilly GS; Elahi D; Minaker KL; Rowe JW
    J Clin Endocrinol Metab; 1987 Aug; 65(2):364-7. PubMed ID: 2885337
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Insulin and glucagon response to glucose and arginine in two patients with "autoimmune" diabetes mellitus.
    Del Prete GF; Tiengo A; Bersani G; Nosadini R; Garotti C; Trisotto A
    Horm Metab Res; 1976 Mar; 8(2):149-50. PubMed ID: 1261966
    [No Abstract]   [Full Text] [Related]  

  • 59. [Pancreatic glucagon (IRG), enteroglucagon (EG)].
    Kawabe K; Ito T
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():529-32. PubMed ID: 20960825
    [No Abstract]   [Full Text] [Related]  

  • 60. Elevated plasma levels of glucagon-like peptide-1 after oral glucose ingestion in patients with pancreatic diabetes.
    Hiroyoshi M; Tateishi K; Yasunami Y; Maeshiro K; Ono J; Matsuoka Y; Ikeda S
    Am J Gastroenterol; 1999 Apr; 94(4):976-81. PubMed ID: 10201468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.